GlassScriptPhysician profile
Gerald L Zeavin
NPI 1962459214
$3,232.21
in general payments reported to CMS, 2019-2025
17 companies · $436 in 2025
The $436 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $445 · 2020: $415 · 2021: $430 · 2022: $252 · 2023: $531 · 2024: $723 · 2025: $436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,689.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,689.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $670.82 | 2022-2025 | Durysta, Lumigan, Alphagan P |
| Alcon Vision LLC | $527.38 | 2019-2025 | Clareon, Rocklatan, Hydrus Microstent |
| Allergan, INC. | $514.37 | 2019-2021 | |
| Rxsight INC | $253.24 | 2023-2024 | Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Aerie Pharmaceuticals, INC. | $236.70 | 2019-2021 | |
| Horizon Therapeutics Plc | $216.12 | 2020-2023 | Tepezza |
| Mallinckrodt Hospital Products INC. | $157.85 | 2024-2025 | Acthar |
| Sun Pharmaceutical Industries INC. | $124.41 | 2021-2025 | Cequa |
| Sight Sciences, INC. | $121.98 | 2022-2025 | Omni Surgical System, Sion Surgical Instrument |
| Bausch & Lomb Americas INC. | $110.13 | 2022-2025 | Xiidra, Miebo, Vyzulta |
| Oyster Point Pharma, INC. | $73.43 | 2022-2025 | Tyrvaya |
| Tarsus Pharmaceuticals, INC. | $68.91 | 2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $48.28 | 2019-2021 | |
| Biotissue Holdings INC. | $40.78 | 2023-2024 | |
| Dompe US, INC. | $32.18 | 2025 | Oxervate |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $18.37 | 2020 | |
| Thea Pharma INC. | $17.26 | 2025 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Zeavin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.